Key facts
- Notable investors include Draper Associates, Boost VC, Spacecadet Ventures, 2048 Ventures, Ensemble VC.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Kascaid
- ·The full record, as it builds
Funding rounds
No funding rounds for Kascaid are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kascaid
Developer of molecular diagnostics technology designed for point-of-care clinical use. The company's platform provides rapid, lab-quality molecular measurements without central labs, enabling healthcare providers and researchers to streamline workflows, improve diagnostic precision, accelerate trials, and support timely, data-driven treatment decisions.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2025
- Website
- kascaid.bio/
- Ownership
- Privately Held (backing)
Kascaid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kascaid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kascaid in its N-PORT filings yet. We sweep new filings monthly.